Neuroregeneration is the growth or repair of neural cells and tissues following damage or injury. Discover the latest research on neuroregeneration here.

January 8, 2021
Open Access

Chronic lung diseases: prospects for regeneration and repair

European Respiratory Review : an Official Journal of the European Respiratory Society
Peter J BarnesMaria G Belvisi
January 13, 2021

Changes in proteins related to early nerve repair in a rat model of sciatic nerve injury

Neural Regeneration Research
Yu-Song YuanYu-Hui Kou
January 5, 2021
Open Access

Niche Cells Crosstalk In Neuroinflammation After Traumatic Brain Injury

International Journal of Biological Sciences
Yibin JiaXiaosheng He
January 10, 2021

Exosomes Produced by Adipose-derived Stem Cells Inhibit Schwann Cells Autophagy and Promote the Regeneration of the Myelin Sheath

The International Journal of Biochemistry & Cell Biology
Gang YinHaodong Lin
January 8, 2021
Open Access

Graphene Oxide and Reduced Derivatives, as Powder or Film Scaffolds, Differentially Promote Dopaminergic Neuron Differentiation and Survival

Frontiers in Neuroscience
Noela Rodriguez-LosadaJose A Narvaez
January 9, 2021

Mortality in mental health patients of the Emilia-Romagna region of Italy: A registry-based study

Psychiatry Research
Domenico BerardiAngelo Fioritti
January 13, 2021

The interaction of stem cells and vascularity in peripheral nerve regeneration

Neural Regeneration Research
Sara SaffariAlexander Y Shin
January 6, 2021

Aligned Graphene Mesh-Supported Double Network Natural Hydrogel Conduit Loaded with Netrin-1 for Peripheral Nerve Regeneration

ACS Applied Materials & Interfaces
Qun HuangXinwu Lu
January 13, 2021
Open Access

New Data on Cylindrospermopsin Toxicity

Mariela ChichovaHristo Gagov
January 13, 2021

Cholesterol synthesis inhibition promotes axonal regeneration in the injured central nervous system

Neurobiology of Disease
Alireza P ShabanzadehPhilippe P Monnier
January 12, 2021
Open Access

Effect of Cyclic Stretch on Neuron Reorientation and Axon Outgrowth

Frontiers in Bioengineering and Biotechnology
Ji LinJin Qian
January 8, 2021
Open Access

A Review on Mesenchymal Stem Cells for Treatment of Retinal Diseases

Stem Cell Reviews and Reports
Sanjucta AdakBithiah Grace Jaganathan
January 9, 2021
Open Access

Simvastatin Influences Selected Aspects of Duchenne Muscular Dystrophy Pathology in a Mouse Model

Olga MuchaAgnieszka Łoboda
January 12, 2021
Open Access

Regeneration of Functional Neurons After Spinal Cord Injury via in situ NeuroD1-Mediated Astrocyte-to-Neuron Conversion

Frontiers in Cell and Developmental Biology
Brendan PulsGong Chen
January 11, 2021

Understanding and treating paediatric hearing impairment

Christian WrobelTobias Moser
January 13, 2021
Open Access

Mesenchymal Stem Cell Treatment Perspectives in Peripheral Nerve Regeneration: Systematic Review

International Journal of Molecular Sciences
Andrea LavoratoDiego Garbossa
January 12, 2021
Open Access

Isolation and characterization of neural crest-like progenitor cells in human umbilical cord blood

Regenerative Therapy
Zena Al-BakriTaro Matsumoto

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2021 Meta ULC. All rights reserved